Lung Cancer-targets And Therapy

Lung Cancer - Targets and Therapy is a peer-reviewed open access journal dedicated to the treatment goals and therapies for lung cancer. This journal covers multiple aspects such as lung cancer diagnosis, molecular targeted therapy, immunotherapy, drug development, clinical trials, and basic scientific research related to treatment. It aims to provide a platform for lung cancer researchers, clinical doctors, and other healthcare professionals to exchange the latest research findings and treatment strategies.

The magazine has had a significant impact on the scientific development and clinical practice of lung cancer treatment by publishing high-quality research articles. The open access policy of journals promotes knowledge sharing globally and accelerates the translation of research results into clinical applications. It is an authoritative resource in the field of lung cancer research and treatment, providing professionals with a timely channel to stay informed about the latest research trends and treatment strategies. By reading this journal, medical professionals can gain valuable information for improving patient care and advancing the discipline.

《肺癌-靶点和治疗》是一本专注于肺癌治疗目标和疗法的同行评审开放获取期刊。该期刊涵盖了肺癌诊断、分子靶向治疗、免疫治疗、药物开发、临床试验以及治疗相关的基础科学研究等多个方面。它旨在为肺癌研究人员、临床医生和其他医疗保健专业人员提供一个交流最新研究成果和治疗策略的平台。

杂志通过发表高质量的研究文章，对肺癌治疗领域的科学发展和临床实践产生了重要影响。期刊的开放获取政策促进了全球范围内的知识共享，加速了研究成果向临床应用的转化。它是肺癌研究和治疗领域的权威资源，它为专业人士提供了一个及时了解最新研究趋势和治疗策略的渠道。通过阅读该期刊，医疗专业人员可以获得宝贵的信息，用于改善患者护理和推动学科前进。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映ONCOLOGY领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为5.1，平均审稿速度为 16 Weeks ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。